Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Tianjin Pharmaceutical Da Ren Tang Group has announced the completion of its disposal of a 13% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. This strategic move, classified as an interested person transaction, reflects the company’s efforts to optimize its investment portfolio and potentially enhance shareholder value.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.